Structured evidence table for Chlorella Blood Lipids Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Chlorella Blood Lipids Randomized Trial | It is imperative to develop a sustainable food system with a reduced environmental footprint [,,]. | 3 | Zhang Xiaomei (2026) | Microalgae as Novel Food Resources: Technological Breakthroughs, Application Bottlenecks, and Future Pathways |
| Chlorella Blood Lipids Randomized Trial | We synthesize evidence on nutritional evaluation, application scenarios, and global regulatory differences, and analyze key bottlenecks. | 3 | Zhang Xiaomei (2026) | Microalgae as Novel Food Resources: Technological Breakthroughs, Application Bottlenecks, and Future Pathways |
| Chlorella Blood Lipids Randomized Trial | These advances include improvements in cultivation systems such as closed photobioreactors and optimized open-pond systems that have enhanced biomass productivity and reduced contamination risks []. | 3 | Zhang Xiaomei (2026) | Microalgae as Novel Food Resources: Technological Breakthroughs, Application Bottlenecks, and Future Pathways |
| Chlorella Blood Lipids Randomized Trial | 1 2 3 4 According to United Nations projections, the global population is expected to continue growing over the next 50–60 years, peaking at approximately 10.3 billion around the mid-2080s []. | 3 | Zhang Xiaomei (2026) | Microalgae as Novel Food Resources: Technological Breakthroughs, Application Bottlenecks, and Future Pathways |
| Chlorella Blood Lipids Randomized Trial | Chlorella 5 7 8 9 10 Emerging evidence suggests that supplementation withand spirulina may be associated with improvements in metabolic parameters such as insulin sensitivity, lipid profiles, and hepatic steatosis markers while simultaneously reducing systemic inflammatory burden and oxidative stress. | 3 | Rzeski Wojciech (2026) | Chlorella and Arthrospira (Spirulina) as Multi-Pathway Biological Response Modulators: Molecular Mechanisms, Signaling Pathways and Clinical Evidence |
| Chlorella Blood Lipids Randomized Trial | We also discuss clinical evidence, safety considerations, and translational perspectives, highlighting current knowledge gaps and future research directions necessary for the rational development of microalgae-based interventions in preventive and integrative medicine. | 3 | Rzeski Wojciech (2026) | Chlorella and Arthrospira (Spirulina) as Multi-Pathway Biological Response Modulators: Molecular Mechanisms, Signaling Pathways and Clinical Evidence |
| Chlorella Blood Lipids Randomized Trial | 2 7 19 In spirulina, phycobiliproteins, particularly phycocyanin, are the dominant pigment-derived bioactives, with documented antioxidant and anti-inflammatory activity and emerging evidence for metabolic signaling effects including Nrf2 activation and the attenuation of oxidative stress in preclinical models [,,]. | 3 | Rzeski Wojciech (2026) | Chlorella and Arthrospira (Spirulina) as Multi-Pathway Biological Response Modulators: Molecular Mechanisms, Signaling Pathways and Clinical Evidence |
| Chlorella Blood Lipids Randomized Trial | Chlorella Arthrospira Microalgae represent a diverse group of aquatic photosynthetic microorganisms and a rich source of bioactive compounds with significant potential in functional foods, nutraceuticals, and preventive medicine. | 3 | Rzeski Wojciech (2026) | Chlorella and Arthrospira (Spirulina) as Multi-Pathway Biological Response Modulators: Molecular Mechanisms, Signaling Pathways and Clinical Evidence |
Source documents